Concentric by Ginkgo announced that it has entered into a Co-Marketing Agreement with Illumina, Inc. to partner on expanding biosecurity capabilities globally. Concentric is building a global pathogen monitoring network?a "bioradar" system ?in countries around the world to detect, characterize, and rapidly respond to biological threats and help drive informed decision-making in support of global health objectives. With over a dozen countries actively scoping and hosting biosecurity programs with Concentric's platform of integrated services, the bioradar network can serve to bolster national security and early warning capabilities for countries.

Illumina is a global leader in DNA sequencing and array-based technologies, serving customers in the research, clinical, and applied markets. Illumina offers a range of leading next-generation sequencing instruments, consumables, and software to understand pathogens in ways not previously possible. These solutions can be leveraged to interrogate many different types of specimens, to enable stakeholders with a full understanding of circulating threats.

Under the agreement, the partners aim to demonstrate the use of Illumina products with Concentric's bioradar, to accelerate the expansion of the pathogen monitoring network in a way that empowers countries, as well as increase the scale and scope of pathogen genomic surveillance globally. Concentric and Illumina will work together to market their solutions, with the aim to enhance early warning of emerging and novel pathogens and fill gaps in global biosurveillance infrastructure. The shared goal is to help build local capacity for biosurveillance to empower countries rather than having to outsource biosecurity to unreliable third parties.

Together, Concentric and Illumina are working to help ensure that nations worldwide are equipped and empowered, locally and sustainably.